chevron_leftBack
As of 13 June 2026, PharmaCyte Biotech, Inc. has a market cap of $8.03M USD, ranking #42394 globally and #5447 in the United States.
It ranks #3751 in the Healthcare sector, and #260 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$8.03MUSD
Enterprise Value
-$12.51MUSD
Net Income (TTM)
-$7.49MUSD
PB Ratio
0.2
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Joshua Silverman
open_in_new
Employees
2
Founded
1996
Website
pharmacyte.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.6% | -2.9% | 5.7% | -17% | -24% | -38% |
News
Loading...
PMCB Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PMCB
PharmaCyte Biotech Inc
ISIN: US71715X2036
Shares Out.:
Shares Outstanding:
10.736M1
Shares Float:
10.069M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
0.7481 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
368K%
|
-
|
|
LSE: INDV
|
$2.07B
26K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
22K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
22K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
16K%
|
-
|
|
NYSE: BRBR
|
$1.02B
13K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.75B
458K%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.84B
197K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
139K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
137K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
113K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.74B
109K%
7.57B EUR
|
-
|
chevron_leftBack